Hemoglobinuria, Paroxysmal - 24 Studies Found Completed : Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients : Hemoglobinuria, Paroxysmal : 2010-10-18 Completed : Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent PNH Subjects : Hemoglobinuria, Paroxysmal : 2009-03-23 : Drug: Eculizumab Other Name: Soliris Completed : The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) : Hemoglobinuria, Paroxysmal : 2008-07-23 Approved for marketing : The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol : Hemoglobinuria, Paroxysmal : 2007-02-20 : Drug: eculizumab 600mg IV every week and 900mg IV every 2 weeks Completed : Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients : Hemoglobinuria, Paroxysmal : 2005-07-18 : Drug: eculizumab Completed : Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab : Hemoglobinuria, Paroxysmal : 2005-07-19 : Drug: eculizumab Completed : Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria : Paroxysmal Hemoglobinuria, Nocturnal : 2005-08-11 : Drug: Eculizumab Completed : Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria : Paroxysmal Hemoglobinuria : 2002-06-14 Recruiting : Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of RO7112689 in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria : Paroxysmal Hemoglobinuria, Nocturnal : 2016-11-01 : Drug: RO7112689 RO7112689 will Completed : Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) : Paroxysmal Hemoglobinuria, Nocturnal : 2005-07-20 : Drug: eculizumab 600 mg intrav Next >>>